Patented
Know-how based
Licensee
Development partner
Commercial partner
Atherosclerosis is the buildup of fatty deposits that can clog arteries. Estrogen is protective for the skeletal and cardiovascular systems. As such, the risk of atherogenesis increases post-menopause in women.
Researchers at Saint Louis University have demonstrated that induction of TcREG reduces atherosclerosis.
The potential benefits of this technology include:
Increasing the effectiveness of treatments
Minimizing the safety risks associated with treatments
Minimizing non-specific effects
Minimizing immune responses to treatments
This technology has potential application for treating atherosclerosis and various resulting diseases including:
Angina
Carotid artery disease
Chronic kidney disease
Coronary heart disease
Peripheral artery disease
Saint Louis University is seeking a partner to further develop and commercialize this technology.